📖

nimodipine-als

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-nimodipine-als

Related Entities

clinical-trials-nimodipine-als

Metadata

slug	clinical-trials-nimodipine-als
entity_type	clinical_trial
kg_node_id	None

Linked Artifacts (280)

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming63%

mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme60%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%

mentions🔬What are the mechanisms underlying rna binding protein dysre60%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%

mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%

mentions🔬RNA binding protein dysregulation across ALS FTD AD60%

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%

related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%

related🧫Metabolic Pathway-Targeted Therapy in ALS60%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%

related🧫Brainstem Circuit Modulation for PSP60%

related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%

related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%

related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%

related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%

related🧫N-of-1 Clinical Trial Design for CBS/PSP60%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%

related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%

related🧫Progranulin Replacement Therapy for FTD — Vector Development60%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%

related🧫PSP and CBS Biomarker Validation Study60%

related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%

related🧫TDP-43 PET Ligand Development for FTD and ALS60%

related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%

see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%

see_also📖a2m60%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%

related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro55%

related🧪Adenosine-Astrocyte Metabolic Reset55%

related🧪Noradrenergic-Tau Propagation Blockade55%

related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%

related🧪Circadian-Gated Maresin Biosynthesis Amplification55%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%

related🧪Mitochondrial SPM Synthesis Platform Engineering55%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer55%

related🧪APOE Isoform Conversion Therapy55%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction55%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy55%

related🧪APOE4-Selective Lipid Nanoemulsion Therapy55%

related🧪Competitive APOE4 Domain Stabilization Peptides55%

related🧪APOE Isoform Expression Across Glial Subtypes55%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal55%

related🧪SASP-Driven Aquaporin-4 Dysregulation55%

related🧪Aquaporin-4 Polarization Rescue55%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna55%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes55%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation55%

related🧪Lysosomal Membrane Repair Enhancement55%

related🧪Extracellular Vesicle Biogenesis Modulation55%

related🧪Temporal Decoupling via Circadian Clock Reset55%

related🧪Circadian Clock-Autophagy Synchronization55%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors55%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor55%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri55%

related🧪CYP46A1 Overexpression Gene Therapy55%

related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor55%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset55%

related🧪Transcriptional Autophagy-Lysosome Coupling55%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming55%

related🧪Liquid-Liquid Phase Separation Modifier Therapy55%

related🧪Stress Granule Phase Separation Modulators55%

related🧪Phase-Separated Organelle Targeting55%

related🧪RNA Granule Nucleation Site Modulation55%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation55%

related🧪Targeted Butyrate Supplementation for Microglial Phenotype M55%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue55%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition55%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization55%

related🧪The Glial Ketone Metabolic Shunt Hypothesis55%

related🧪Axonal RNA Transport Reconstitution55%

related🧪Lysosomal Enzyme Trafficking Correction55%

related🧪Lysosomal Positioning Dynamics Modulation55%

related🧪Lysosomal Calcium Channel Modulation Therapy55%

related🧪Mitochondrial Transfer Pathway Enhancement55%

related🧪APOE-Dependent Autophagy Restoration55%

related🧪Nucleolar Stress Response Normalization55%

related🧪Microglial Purinergic Reprogramming55%

related🧪Purinergic P2Y12 Inverse Agonist Therapy55%

related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption55%

related🧪Extracellular Matrix Stiffness Modulation55%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation55%

related🧪Perforant Path Presynaptic Terminal Protection Strategy55%

related🧪Arginine Methylation Enhancement Therapy55%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc55%

related🧪Mitochondrial-Lysosomal Contact Site Engineering55%

related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy55%

related🧪R-Loop Resolution Enhancement Therapy55%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme54%

related🔬What are the mechanisms underlying tdp-43 phase separation t54%

related🔬What are the mechanisms underlying rna binding protein dysre54%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%

related🔬Analyze the spectrum of microglial activation states (DAM, h54%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%

related🔬RNA binding protein dysregulation across ALS FTD AD54%

related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%

related🔬RNA binding protein dysregulation across ALS FTD and AD54%

related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%

related🧫Metabolic Pathway-Targeted Therapy in ALS54%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%

related🧫Brainstem Circuit Modulation for PSP54%

related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%

related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%

related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%

related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%

related🧫N-of-1 Clinical Trial Design for CBS/PSP54%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%

related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%

related🧫Progranulin Replacement Therapy for FTD — Vector Development54%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%

related🧫PSP and CBS Biomarker Validation Study54%

related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%

related🧫TDP-43 PET Ligand Development for FTD and ALS54%

related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%

mentions🧫Mouse Cdk5, p35, and p39 mutations in neuronal migration50%

mentions🧫Reelin pathway defects in human type 2 lissencephaly50%

mentions🧫MAP6 depletion effects on neuronal development in primary cu50%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 50%

mentions🧫Prion Strain Diversity and Selective Vulnerability50%

mentions🧫Microtubule domain analysis in adult axons50%

mentions🧫Tau depletion effects on neuronal development in primary cul50%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%

mentions🧪Cryptic Exon Silencing Restoration50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

mentions🧪Cross-Seeding Prevention Strategy50%

mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%

mentions🧪Noradrenergic-Tau Propagation Blockade50%

mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%

mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

mentions🧪Aquaporin-4 Polarization Rescue50%

mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪SASP-Mediated Complement Cascade Amplification50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Complement C1q Subtype Switching50%

mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%

mentions🧪Lysosomal Membrane Repair Enhancement50%

mentions🧪Extracellular Vesicle Biogenesis Modulation50%

mentions🧪Temporal Decoupling via Circadian Clock Reset50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%

mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪Stress Granule Phase Separation Modulators50%

mentions🧪Phase-Separated Organelle Targeting50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%

mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%

mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%

mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

mentions🧪Orexin-Microglia Modulation Therapy50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%

mentions🧪HDAC3-Selective Inhibition for Clock Reset50%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

mentions🧪Axonal RNA Transport Reconstitution50%

mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

mentions🧪Lysosomal Enzyme Trafficking Correction50%

mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%

mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%

mentions🧪Lysosomal Positioning Dynamics Modulation50%

mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%

mentions🧪Mitochondrial Transfer Pathway Enhancement50%

mentions🧪Nucleolar Stress Response Normalization50%

mentions🧪Netrin-1 Gradient Restoration50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

mentions🧪Microglial Purinergic Reprogramming50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%

mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🧪Synaptic Vesicle Tau Capture Inhibition50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

mentions🧪Autophagosome Maturation Checkpoint Control50%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Blood-Brain Barrier SPM Shuttle System50%

mentions🧪Low Complexity Domain Cross-Linking Inhibition50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧪Quantum Coherence Disruption in Cellular Communication50%

mentions🧪VCP-Mediated Autophagy Enhancement50%

mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🧪APOE-TREM2 Interaction Modulation50%

related🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement50%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬Investigate prion-like spreading of tau pathology through co50%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP44%

mentions🧫TRIM21-mediated K63-linked ubiquitination of G3BP144%

mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha44%

mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 44%

mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr44%

mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model44%

mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen44%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%

related🧪Cryptic Exon Silencing Restoration40%

related🧪Glycine-Rich Domain Competitive Inhibition40%

related🧪Cross-Seeding Prevention Strategy40%

related🔬What are the mechanisms underlying selective vulnerability o36%